Genetically modified mice open the door to personalized medicine in rare diseases

An international research team led by Dr. Ana Guadaño at the Alberto Sols Biomedical Research Institute (IIBM, CSIC-UAM joint center) in which the Complutense University of Madrid (UCM) participates introduced into mice -through CRISPR gene editing techniques–, mutation of the protein MCT8, responsible for the transport of thyroid hormones into the interior of the cell. … Read more